IPAR options flag caution ahead of November earnings

Interparfums heads into its November 3 earnings release with short sellers trimming positions but options traders abruptly shifting toward defensive territory, a divergence worth watching in a stock that has consistently sold off after recent prints.

The options signal is the standout this week. The put/call ratio jumped to 0.46 on October 20, almost entirely driven by a single-session shift, against a 20-day average of just 0.16. That puts the reading more than four standard deviations above its recent norm, the most defensive options posture on IPAR in months. For context, the ratio spent the entire previous month below 0.18. Whether that reflects hedging ahead of earnings, new put positioning, or simply thin liquidity in an illiquid options book is unclear. What is clear is that someone paid for downside protection at a level not seen recently.

Short interest tells a calmer story. Bears have been scaling back. The short position has fallen roughly 2.5% over the past week to 6.1% of the free float, continuing a gradual decline from a local peak near 2.08 million shares in mid-October. Borrow costs remain low at 0.52%, barely changed over the month. Availability is loose at 508%, meaning there are roughly five shares available to borrow for every two already shorted. None of this points to a forced-cover situation or squeeze risk. The ORTEX short score of 62.3, down from 64 ten days ago, reflects this easing of short-side pressure.

The Street is split, and that split may explain both the short position and the options hedging. Goldman Sachs and TD Cowen both downgraded to Neutral in August, in Goldman's case raising the target to $129 while removing the Buy, which is a notable move. Jefferies and Canaccord kept Buy ratings with targets at $145 and $151 respectively. BWS Financial has been parked at Neutral with an $85 target since at least January, well below the current price of $115.90, a level the stock has now comfortably exceeded. The consensus mean target is $126.50, about 9% above the current price. The valuation is not cheap at a trailing P/E near 22.5 and EV/EBITDA around 13.3, both of which have crept higher over the past month as the stock has edged up 3%.

The bull case rests on an active launch calendar. U.S. operations posted 18% reported sales growth in Q2, supported by Guess and DKNY momentum, and the second half brings Longchamp's fragrance entry plus 11 new Solférino launches. The bear case is harder to dismiss: Europe and the Middle East together account for around 42% of sales, and Q2 showed Western Europe down 7% and the Middle East down 34%. Management has flagged continued softness in those regions through the rest of 2026. Operating profit missed in Q2 at $49 million against Street expectations of $55.6 million, so the topline beats have not been translating cleanly to the bottom line.

Institutional ownership is stable, with co-founders Jean Madar and Philippe Benacin together holding over 43% of shares. BlackRock added 182,000 shares in Q3, and T. Rowe Price added nearly 147,000. The only recent insider transaction of note was a director's open-market sale of 900 shares in August, a small and routine-looking transaction. Nothing in the ownership picture suggests unusual pressure or urgency.

IPAR fell 7.4% the day after its August earnings print and lost a further 8.1% over the following week. The November 3 release is therefore less about whether innovation momentum continues and more about whether the European and Middle East drag narrows enough to stop the operating margin from missing again.